<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Gammaherpes viruses are often detected in <z:hpo ids='HP_0002665'>lymphomas</z:hpo> arising in immunocompromised patients </plain></SENT>
<SENT sid="1" pm="."><plain>We have found that <z:chebi fb="1" ids="10110">Azidothymidine</z:chebi> (<z:chebi fb="39" ids="10110">AZT</z:chebi>) alone induces <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in Epstein Barr Virus (EBV) positive Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) cells but requires interferon alpha (IFN-alpha) to induce <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in Human <z:e sem="disease" ids="C0019340" disease_type="Disease or Syndrome" abbrv="">Herpes</z:e> Virus Type 8 (HHV-8) positive Primary Effusion <z:hpo ids='HP_0002665'>Lymphomas</z:hpo> (PEL) </plain></SENT>
<SENT sid="2" pm="."><plain>Our analysis of a series of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> <z:hpo ids='HP_0002665'>lymphomas</z:hpo> revealed that IFN-alpha selectively induced very high levels of the <z:hpo ids='HP_0011420'>Death</z:hpo> Receptor (DR) <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-related <z:mpath ids='MPATH_3'>apoptosis</z:mpath>-inducing ligand (TRAIL) in HHV-8 positive PEL lines and <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> cells whereas little or no induction was observed in primary EBV+ <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and EBV-Burkitt's lines </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="39" ids="10110">AZT</z:chebi> and IFN-alpha mediated <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in PEL was blocked by stable overexpression of dominant negative Fas Associated <z:hpo ids='HP_0011420'>Death</z:hpo> Domain (FADD), decoy receptor 2 (DcR2), soluble TRAIL receptor fusion proteins (DR-4 and DR-5) and <z:chebi fb="0" ids="17748">thymidine</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>Trimeric TRAIL (in place of IFN-alpha) similarly synergized with <z:chebi fb="39" ids="10110">AZT</z:chebi> to induce <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in HHV-8 positive PEL cells </plain></SENT>
<SENT sid="5" pm="."><plain>This is the first demonstration that IFN-alpha induces functional TRAIL in a <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> that can be exploited to effect a <z:e sem="disease" ids="C0812393,C0038661" disease_type="Mental or Behavioral Dysfunction;Injury or Poisoning" abbrv="">suicide</z:e> program </plain></SENT>
<SENT sid="6" pm="."><plain>This novel antiviral approach to Primary Effusion <z:hpo ids='HP_0002665'>lymphomas</z:hpo> is targeted and may represent a highly effective and relatively non-toxic therapy </plain></SENT>
</text></document>